Study raises new concerns about PPI risks

Proton pump inhibitors (PPIs) put patients at risk of premature death, according to a longitudinal observational study published in BMJ Open.

A team of researchers analysed the data of more than six million people obtained from the US Department of Veterans Affairs to compare the risk of death among those using PPIs or H2 blockers.